Karyopharm Therapeutics (KPTI) Net Equity Issued and Repurchased (2013 - 2015)
Karyopharm Therapeutics' (KPTI) quarterly Net Equity Issued and Repurchased came in at $91.0 million in Q1 2015, down 19.35% on a QoQ basis from $112.8 million in Q4 2013.
Karyopharm Therapeutics (KPTI) Net Equity Issued and Repurchased (2013 - 2015) Analysis & Trends
Karyopharm Therapeutics (KPTI) has 2 years of Net Equity Issued and Repurchased data on file, last reported at $91.0 million in Q1 2015.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $91.0 million in Q1 2015, while the trailing twelve-month figure through Mar 2015 was $203.8 million (changed N/A YoY) and the FY2025 annual result came in at $100.0 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased slipped to $91.0 million in Q1 2015, from $112.8 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $112.8 million in Q4 2013 to a low of $91.0 million in Q1 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Karyopharm Therapeutics | 56.72 Mn | 56.72 Mn | 32.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | 90.99 Mn |
| Mar 31, 2015 | 90.99 Mn |
| Dec 31, 2013 | 112.82 Mn |
| Dec 31, 2013 | 112.82 Mn |